Preview Mode Links will not work in preview mode


Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of precision medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age-related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

Aug 10, 2022

Jenny Ahlstrom is the Founder and CEO of the HealthTree Fouon and a multiple myeloma patient and patient advocate. The HealthTree Foundation was the winner of the GSK Target the Future Think Tank Challenge and will receive financial support and technical expertise to extend equal access and diversity in multiple myeloma research, clinical trials, services, and education. This effort includes patient navigators who are members of the Black community as well as Spanish speakers who can provide patients access to material translated into Spanish.

Jenny explains, "I was diagnosed in 2010 and had some hypotheses about what I wanted in terms of my own therapy and my own types of support that I was looking for. And so, in 2012, we started the foundation, and we have been building up different patient programs for multiple myeloma over that long period of time. We've just gone to look and see what is available already in terms of support services. Then we identified different gaps that we saw as patients ourselves and tried to fill those gaps. And that's been the primary effort of our work, to fill those gaps for patients."

"So, we are going to apply this funding to our equity and diversity program. And specifically on this website. This website will do outreach to the African American community. Like I said, they are two or three times more likely to develop multiple myeloma. And it's really essential that they learn broadly about what multiple myeloma is."

@HealthTree #HealthTreeFoundation #GSK #TargettheFuture #MultipleMyeloma #PatientAdvocate

Download the transcript here


Interview with Dr. Tania Small GSK

Podcast and Transcript